Skip to content

Construction of palliative care intervention scheme based on the needs of patients with hematologic malignancy

Construction of palliative care intervention scheme based on the needs of patients with hematologic malignancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084330
Enrollment
Unknown
Registered
2024-05-14
Start date
2024-05-18
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematologic malignancy

Interventions

Observation Group:None

Sponsors

The First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ? Patients with hematologic tumors confirmed by clinicopathology (including acute and chronic leukemia, lymphoma, multiple myeloma, etc.);? Age =18 years old; ? Clear consciousness, no cognitive impairment, basic language communication skills, able to understand others and communicate smoothly; ? Willing to cooperate with investigators.

Exclusion criteria

Exclusion criteria: Exclusion criteria: ? accompanied by serious diseases unrelated to hematologic tumors; ? Patients who are physically unable to complete the survey or interview; ? The patient is unaware of his condition and his family members protect the patient's condition.

Design outcomes

Primary

MeasureTime frame
Palliative needs;

Secondary

MeasureTime frame
Severity of patient's symptoms;Level of patient social support;Patient's level of depression and anxiety;

Countries

China

Contacts

Public ContactZhang yuxi

The First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital)

zhangyuxi830@163.com+86 135 8403 1657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026